News

Terumo Corp. Arterial Remodeling Technologies Bioresorbable Coronary Stent

Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo Corp. Under the agreement, ART and Terumo Corp. will collaborate in the development of a drug...

InspireMD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European...

Medtronic Endeavor Stents Drug-eluting Antiplatelet Therapy Clinical Study

Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from Medtronic Inc. and subsequently interrupted their dual ...

Boston Scientific Rebel Platinum Chromium Coronary Stent System Bare Metal

Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the company's latest generation ...

Micell Technologies Inc. announced that imaging and clinical results from the DESSOLVE I and DESSOLVE II trials...

March 3, 2014 — OrbusNeich announced that patient enrollment has initiated in Japan in the pivotal clinical trial of the Combo dual-therapy stent, employing a single Japan-U.S. protocol conducted...

Percuntaneous Coronary Intervention PCI Cath Lab Stents Clinical Trial Study

Expanded use of percutaneous coronary intervention (PCI) is seeing more patients with acute coronary syndromes treated more quickly, according to the latest National ...

Veniti Vici Venous Stent System Venous Therapies Clinical Study CE Mark

Patients in the European Union (EU) received the first Veniti Vici Venous Stent System implants to treat symptomatic...

Espirt Bioresorbable Vascular Scaffold BVS Peripheral Artery Disease PAD

Six-month results of the ESPRIT trial suggest a bioresorbable drug-eluting scaffold is effective in opening...

Reva Medical ReZolve2 Bioresorbable Scaffold Stent Clinical Trial

An implant of the ReZolve2 bioresorbable scaffold was transmitted live via satellite at the Transcatheter...

Carotid Stent Clinical Study Abbott Cordis National Cardiovascular Data Registry

The three most common systems to place stents in blocked carotid arteries of the neck have similarly low rates of...

Elixir Medical DESolve Bioresorbable Coronary Scaffold System Stents

The first commercial implant of Elixir Medical’s CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany. Elixir’s fully ...

cath lab stents bioresorbable amaranth fortitude scaffold

Amaranth Medical announced the closing of an equity investment by Boston Scientific Corp.

stentys self-apposing stent clinical trial study TCT 2013 cath lab

Stentys, developer of the world's first self-apposing stent to treat acute myocardial infarction (AMI), announced...

ACC, iPad cardiology apps

DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.

balloon catheters peripheral artery disease intact vascular tack-it

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced the start of enrollment in the Tack Optimized ...

cath lab stents carotid stroke treament trial study balloon john hopkin

Johns Hopkins Hospital surgeons say skipping one commonly taken step during a routine procedure to insert a wire mesh stent into a partially blocked carotid artery appears to prevent patients from...

cath lab stents drug eluting boston scientific promus premier

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's durable...

renal stenting

The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in patient outcomes over the use of medications alone in treating hypertension....

clinical trial study stents cath lab mguard inspiremd

InspireMD Inc., a developer of embolic protection stents, announced 12-month results from the MGuard for Acute ST Elevation Reperfusion (MASTER) ...